These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36385399)

  • 21. Haploidentical Transplants with Post-Transplant Cyclophosphamide for Relapsed or Refractory Hodgkin Lymphoma: The Role of Comorbidity Index and Pretransplant Positron Emission Tomography.
    Marani C; Raiola AM; Morbelli S; Dominietto A; Ferrarazzo G; Avenoso D; Giannoni L; Varaldo R; Gualandi F; Grazia D; Lamparelli T; Bregante S; Van Lint MT; Ibatici A; Bovis F; Lemoli RM; Gobbi M; Bacigalupo A; Angelucci E
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):2501-2508. PubMed ID: 30041010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia.
    Terwey TH; Hemmati PG; Martus P; Dietz E; Vuong LG; Massenkeil G; Dörken B; Arnold R
    Haematologica; 2010 May; 95(5):810-8. PubMed ID: 20007143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation.
    Wenger DS; Triplette M; Crothers K; Cheng GS; Hill JA; Milano F; Shahrir S; Schoch G; Vande Vusse LK
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):413-420. PubMed ID: 31605819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.
    Lin CJ; Vader JM; Slade M; DiPersio JF; Westervelt P; Romee R
    Cancer; 2017 May; 123(10):1800-1809. PubMed ID: 28262921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infection-related mortality after HLA-identical and haploidentical hematopoietic cell transplantation using reduced-intensity conditioning in an outpatient setting.
    Jaime-Pérez JC; Meléndez-Flores JD; Ramos-Dávila EM; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Marfil-Rivera LJ; Áncer-Rodríguez J; Gómez-Almaguer D
    Clin Transplant; 2023 Jun; 37(6):e14972. PubMed ID: 36943871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.
    Ahmed S; Ghosh N; Ahn KW; Khanal M; Litovich C; Mussetti A; Chhabra S; Cairo M; Mei M; William B; Nathan S; Bejanyan N; Olsson RF; Dahi PB; van der Poel M; Steinberg A; Kanakry J; Cerny J; Farooq U; Seo S; Kharfan-Dabaja MA; Sureda A; Fenske TS; Hamadani M
    Br J Haematol; 2020 Aug; 190(4):573-582. PubMed ID: 32314807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.
    Majhail NS; Brazauskas R; Rizzo JD; Sobecks RM; Wang Z; Horowitz MM; Bolwell B; Wingard JR; Socie G
    Blood; 2011 Jan; 117(1):316-22. PubMed ID: 20926773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
    Phelan R; Im A; Hunter RL; Inamoto Y; Lupo-Stanghellini MT; Rovo A; Badawy SM; Burns L; Eissa H; Murthy HS; Prasad P; Sharma A; Suelzer E; Agrawal V; Aljurf M; Baker K; Basak GW; Buchbinder D; DeFilipp Z; Grkovic LD; Dias A; Einsele H; Eisenberg ML; Epperla N; Farhadfar N; Flatau A; Gale RP; Greinix H; Hamilton BK; Hashmi S; Hematti P; Jamani K; Maharaj D; Murray J; Naik S; Nathan S; Pavletic S; Peric Z; Pulanic D; Ross R; Salonia A; Sanchez-Ortega I; Savani BN; Schechter T; Shah AJ; Smith SM; Snowden JA; Steinberg A; Tremblay D; Vij SC; Walker L; Wolff D; Yared JA; Schoemans H; Tichelli A
    Transplant Cell Ther; 2022 Jun; 28(6):335.e1-335.e17. PubMed ID: 34757220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium.
    Rangarajan HG; Stanek JR; Abdel-Azim H; Modi A; Haight A; McKinney CM; McKeone DJ; Buchbinder DK; Katsanis E; Abusin GA; Ahmed I; Law J; Silva JG; Mallhi KK; Burroughs LM; Shah N; Shaw PJ; Greiner R; Shenoy S; Pulsipher MA; Abu-Arja R
    Transplant Cell Ther; 2022 Jun; 28(6):329.e1-329.e9. PubMed ID: 35288346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Slade M; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Romee R
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1736-1743. PubMed ID: 28688919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants.
    Majhail NS; Brunstein CG; McAvoy S; DeFor TE; Al-Hazzouri A; Setubal D; Arora M; Le CT; Wagner JE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):985-992. PubMed ID: 18721761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation.
    Hashmi S; Oliva JL; Liesveld JL; Phillips GL; Milner L; Becker MW
    Leuk Res; 2013 Sep; 37(9):1052-6. PubMed ID: 23830733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation.
    Veeraputhiran M; Yang L; Sundaram V; Arai S; Lowsky R; Miklos D; Meyer E; Muffly L; Negrin R; Rezvani A; Shizuru J; Weng WK; Johnston L
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1744-1748. PubMed ID: 28668491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation.
    Lewis C; Kim HT; Roeker LE; Cutler C; Koreth J; Nikiforow S; Armand P; Gootpu M; Romee R; Glotzbecker B; Nageshwar P; Antin JH; Alyea EP; Richardson P; Soiffer RJ; Ho VT
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):529-539. PubMed ID: 31678537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done?
    Hurley P; Konety S; Cao Q; Weisdorf D; Blaes A
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):300-4. PubMed ID: 25464117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation.
    Pollack SM; Steinberg SM; Odom J; Dean RM; Fowler DH; Bishop MR
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):223-30. PubMed ID: 19167682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative Transplantation With Post-Transplantation Cyclophosphamide in Aplastic Anemia: A Retrospective Report From the BMF-WG of Hunan Province, China.
    Gong S; Chen C; Chen K; Yang R; Wang L; Yang K; Hu J; Nie L; Su T; Xu Y; He X; Yang L; Xiao H; Fu B
    Transplant Cell Ther; 2023 Jan; 29(1):48.e1-48.e7. PubMed ID: 36272527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial foodborne infections after hematopoietic cell transplantation.
    Boyle NM; Podczervinski S; Jordan K; Stednick Z; Butler-Wu S; McMillen K; Pergam SA
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1856-61. PubMed ID: 25020101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.